Pediatrix Medical Group (MD) Competitors

Pediatrix Medical Group (NYSE:MD) and Amedisys (NASDAQ:AMED) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

Which has more volatility and risk, MD or AMED?

Pediatrix Medical Group has a beta of 1.26, indicating that its share price is 26% more volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500.

Do analysts prefer MD or AMED?

Pediatrix Medical Group currently has a consensus price target of $16.67, suggesting a potential upside of 9.97%. Amedisys has a consensus price target of $100.75, suggesting a potential upside of 7.65%. Given Pediatrix Medical Group's stronger consensus rating and higher probable upside, equities analysts clearly believe Pediatrix Medical Group is more favorable than Amedisys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pediatrix Medical Group	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Amedisys	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

Is MD or AMED more profitable?

Amedisys has a net margin of 3.57% compared to Pediatrix Medical Group's net margin of -4.92%. Pediatrix Medical Group's return on equity of 15.47% beat Amedisys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pediatrix Medical Group	-4.92%	15.47%	5.64%
Amedisys	3.57%	12.20%	6.74%

Does the media prefer MD or AMED?

In the previous week, Pediatrix Medical Group had 1 more articles in the media than Amedisys. MarketBeat recorded 6 mentions for Pediatrix Medical Group and 5 mentions for Amedisys. Amedisys' average media sentiment score of 1.67 beat Pediatrix Medical Group's score of 0.92 indicating that Amedisys is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pediatrix Medical Group	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amedisys	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do institutionals and insiders believe in MD or AMED?

97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 94.4% of Amedisys shares are owned by institutional investors. 0.9% of Pediatrix Medical Group shares are owned by company insiders. Comparatively, 2.1% of Amedisys shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Does the MarketBeat Community prefer MD or AMED?

Pediatrix Medical Group received 12 more outperform votes than Amedisys when rated by MarketBeat users. Likewise, 60.12% of users gave Pediatrix Medical Group an outperform vote while only 58.63% of users gave Amedisys an outperform vote.

Company	Underperform	Outperform
Pediatrix Medical Group	Outperform Votes 508 60.12%	Underperform Votes 337 39.88%
Amedisys	Outperform Votes 496 58.63%	Underperform Votes 350 41.37%

Which has better earnings and valuation, MD or AMED?

Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pediatrix Medical Group	$1.98B	0.66	-$60.41M	-$1.01	-15.00
Amedisys	$2.37B	1.30	-$9.75M	$2.71	34.54

Summary

Pediatrix Medical Group and Amedisys tied by winning 9 of the 18 factors compared between the two stocks.